Summary
Orbis Research’s Inclusive Report „Continuous Glucose Monitoring Systems Medical Devices Pipeline Assessment, 2016″ Provide An overview On Market Strategies and Competitive Landscape.
Description
GlobalData’s Medical Devices sector report, “Continuous Glucose Monitoring Systems – Medical Devices Pipeline Assessment, 2016″ provides an overview of Continuous Glucose Monitoring Systems currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Continuous Glucose Monitoring Systems pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/157273
Scope
– Extensive coverage of the Continuous Glucose Monitoring Systems under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Continuous Glucose Monitoring Systems and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry
Purchase a copy of Continuous Glucose Monitoring Systems Market Report visit @ http://www.orbisresearch.com/contact/purchase/157273
Reasons to buy
The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Continuous Glucose Monitoring Systems under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date
Companies Mentioned
- Menarini Diagnostics S.r.l.
Abbott Diabetes Care, Inc.
Advanced Biosensors-Ohio, Llc
Advanced Medical Electronics Corporation
Alcon Inc
Arkal Medical, Inc.
Azurite Technologies, Inc.
Bar-Ilan University
Bellco Srl
Bio-Impedance General Ltd.
Biorasis, Inc.
BioTex Inc
Biovotion AG
Brigham and Women’s Hospital
CALISTO MEDICAL, INC.
Cardiff University
CGM3 Ltd
ConvaTec Healthcare B Sarl
Cyber Medical Ltd.
Debiotech SA
DexCom Inc
DirectSens GmbH
Eccrine Systems Inc
Echo Therapeutics Inc
Ecole Polytechnique Federale de Lausanne
eLutions Integrated Systems, Inc.
EyeSense GmbH
Flowsion A/S
Globe Medical Tech Inc
GlucoLight Corporation
Glucometrics, Inc.
Glucometrix AG
Glucosense Diagnostics Ltd
GlucoSet AS
Glucovation Inc
GluMetrics Inc
Glusense Ltd
GlySens Inc
GlySure Ltd
For any enquires before buying, connect with us @ enquiry@orbisresearch.com
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter: https://twitter.com/orbisresearch
Like us on Facebook: https://www.facebook.com/OrbisResearch